Introduction
the integration machinery and DNA binding proteins has been invoked. Integration was stimulated by a specific interaction between HIV IN and a putative Integration of viral DNA is an essential step in the life cycle of retroviruses and retrotransposons.
transcription activator ( Kalpana et al., 1994) . Perhaps the most compelling example of preferential insertion is Retroviruses can integrate throughout the genome of their hosts. Integration is not random, but the mechathe position-specific integration of the yeast retroviruslike element Ty3, which is targeted by RNA polymerase nisms that determine the positions of integration are poorly understood (Craigie, 1992; Bushman, 1995) . A III transcription factors ( Kirchner et al., 1995) . The yeast retrovirus-like element Ty3 is more closely number of studies indicate that factors influencing the structure of the DNA play a role in target site selection. related to the Drosophila melanogaster gypsy-like retroviruses and to animal retroviruses than to the other Assembly of DNA into nucleosomes enhanced integration into the exposed major groove (Pryciak and yeast retrotransposons ( Hansen et al., 1988) . Ty3 is Varmus, 1992) . Bending of the target DNA by DNA composed of a 4.7-kb internal domain flanked by 340-bp binding proteins or at phased tracts of adenosine resiLTRs (Clark et al., 1988) . Ty3 is distinguished from dues can create favored integration sites in the region other retrotransposons and from retroviruses by its where the DNA is distorted (Muller and Varmus, 1994;  unique integration specificity. De novo Ty3 integrants Pruss et al., 1994b) . Integration was targeted preferenisolated from yeast genomic DNA were shown to be tially into sites that showed the most severe distortion located within 1-2 bp of the site of initiation of trandue to bending of the DNA around nucleosomes (Pruss scription of tRNA genes (Chalker and Sandmeyer, et al., 1994a) . In some examples, interaction between 1990). Subsequently, it was shown that the RNA polymerase-III-transcribed genes, 5S and U6, can also serve as specific targets for Ty3 integration (Chalker and TFIIIB and TFIIIC are required for integration, but would use a human tRNA gene as a target in a similar that RNA polymerase III (pol III ) is not required manner, we needed to determine the position of tran- ( Kirchner et al., 1995; Connolly and Sandmeyer, 1997) .
scription initiation of the human tRNA 3 Lys gene. The A concern to those designing retroviral based gene results from this analysis are shown in Fig. 2 and therapy vectors, is the effect of the integrated vector on diagrammed in Fig. 3 . Primer extension analysis was the expression of genes in the region adjacent to the site performed on total cellular RNAs isolated from yeast of integration. Random integration of a vector could cells transformed with the htRNA 3 Lys gene ( lane 1) and cause aberrant expression of an oncogene or disrupt HeLa cells ( lane 2) using an oligonucleotide specific for expression of a tumor suppressor or other essential gene.
the human tRNA 3 Lys. The major species (indicated by In addition, the region within which integration occurs the arrow) corresponds to the +1 nucleotide of the can have an effect on the level of expression of the mature tRNA. Primer extension of the human therapeutic vector. In contrast, the yeast retrovirus-like tRNA 3 Lys gene transcribed in vivo in either yeast or element Ty3 integrates specifically adjacent to tRNA HeLa cells yields a similar, although not identical, genes without affecting expression of the tRNA gene pattern and the same major RNA species, indicating ( Kinsey and Sandmeyer, 1991) . Thus, tRNA genes that the human tRNA 3 Lys gene is transcribed and procould be a 'safe' site for integration of a therapeutic cessed similarly in yeast and human cells. The 5∞ ends vector. In addition, tRNA genes are redundant in the of longer extension products correspond with potential human genome and, because they are expressed constitutranscription initiation sites at positions -7 and -13 tively, are likely to be located in accessible regions of relative to the first coding base of the mature tRNA. chromatin in many cell types. Therefore, integration
Transcription of a tRNA gene yields a pre-tRNA adjacent to a tRNA gene may lead to more predictable molecule that is processed at the 5∞ and 3∞ ends in order levels of expression of the therapeutic vectors than to form the mature tRNA (Geiduschek and Tocchiniintegration into random sites. Valentini, 1988) . To distinguish the 5∞ ends of the preWe have utilized a plasmid based transposition assay tRNA from the mature tRNA, primer extension analysis to test whether Ty3 integration can be targeted to a was performed on the human tRNA 3 Lys gene transcribed human tRNA gene. This assay enriches for cells in in vitro in yeast pol III transcription extracts ( Klekamp which integration has occurred into the target plasmid, and Weil, 1986; Kassavetis et al., 1989) . The results of but not for the site of integration. When a target these reactions are shown in Fig. 2 , lanes 3-8. Primer containing the human tRNA 3
Lys gene was used, all extension analysis of in vitro transcribed RNA from integration events recovered were shown to be in the the htRNA 3 Lys gene yields a pattern similar to that seen region of transcription initiation, similar to that seen from in vivo transcribed RNA (compare lanes 7 and 1). for a yeast tRNA target gene.
The addition of heparin to the in vitro transcription reaction prevents the re-initiation of RNA polymerase III on the DNA template, resulting in a single round of 2. Experimental and discussion transcription and no processing of the pre-tRNA ( Kassavetis et al., 1990) . Primer extension analysis of 2.1. Construction of target plasmid containing human the in vitro transcribed htRNA 3 Lys gene in the presence tRNALys 3 gene of heparin resulted in products at positions -13, -14, -15, and -16 ( lane 8) . Pol III typically initiates with purine To determine whether a tRNA gene from a heteroloresidues ( White, 1994). Potential transcription initiation gous organism could serve as a target for integration of sites at purines occur at -13, -14, -15, and -16 (refer to the yeast retrovirus-like element Ty3, the human Fig. 3 for nucleotide sequence). tRNA 3
Lys gene was cloned into a yeast high-copy plasmid The dependence of human tRNA 3 Lys gene transcription bearing a selectable marker. The construction of the on the yeast pol III transcription machinery was shown selectable target plasmid bearing the human tRNA 3 Lys using a promoter mutation in the htRNA 3 Lys gene. A gene is described in Fig. 1 . Plasmids pSD1448A-C are C56 to G56 mutation in the box B promoter element individual transformants from the same cloning prowas shown previously to decrease transcription in vitro cedure. Each of these identical plasmids was used as a of the yeast SUP4 tRNATyr gene to 5% of wild type target in the transposition assay.
( Allison et al., 1983) by severely reducing the ability of box B to bind TFIIIC (Baker et al., 1986) . In addition,
Transcription and 5∞ end mapping of human tRNALys
3 it was shown that a G56 promoter mutation abolishes gene in yeast in vivo and in vitro the ability of a tRNA gene to serve as a target for Ty3 integration in vivo (Chalker and Sandmeyer, 1992 ) and Ty3 integrates within 1-2 bp of the site of initiation in vitro ( Kirchner et al., 1995) . A G56 promoter mutaof transcription of tRNA genes in yeast (Chalker and Sandmeyer, 1992) . In order to determine whether Ty3 tion was introduced into the htRNA 3 Lys gene via single- Fig. 1 . Transposition assay. Yeast strain yDLC221 containing a galactose-inducible Ty3 element was transformed with both a low copy URA3 donor plasmid (pDLC348) containing a NmR-marked Ty3 element, Ty3-N, and the high copy LYS2, ApR plasmid containing the human tRNA 3 Lys gene as a target (pSD1448A-C ). The procedure for isolation of integration events into the target plasmid is summarized at the bottom. Methods: Construction of the plasmid pDLC348 and the yeast strain yDLC221 were described previously (Chalker and Sandmeyer, 1992) . The pSD1448A-C plasmids were constructed by cloning the 414-bp HindIII fragment from phtRNA 3 Lys (a generous gift from J. Rosenblatt, U.C. Los Angeles) containing the human tRNA 3 Lys (Roy et al., 1982) gene into the HindIII site, which is proximal to the 3∞ end of the LYS2 gene on the pDP6 plasmid (Fleig et al., 1986) . A 2.2-kb EcoRI fragment from pEGTy3-2 (Hansen et al., 1988) containing the 2-mm element was then cloned into the EcoRI site of the pDP6 plasmid. The pSD1448A-C plasmids are individual transformants from the same cloning procedure. Each of these identical plasmids was used as a target in the transposition assay. The transposition assay was performed as described previously (Chalker and Sandmeyer, 1992) except for the use of a LYS2 marker on the target plasmid instead of a HIS3 marker. Therefore, selective media was deficient in lysine rather than histidine. Lys gene with the same oligonucleotide used in the primer extension reactions (5∞ end-labeled oligonucleotide 357). Methods: Yeast strain yTM443 (Menees and Sandmeyer, 1994) was transformed with pSD1448 and grown in synthetic medium lacking lysine. Yeast cells were harvested and total RNA was extracted as described previously (Clark et al., 1988) . Cytoplasmic RNA was extracted from HeLa cell monolayers as described previously (Dildine and Semler, 1989) . In vitro transcriptions were performed using a yeast extract, BR500, which supports transcription by RNA polymerase III ( Klekamp and Weil, 1986; Kassavetis et al., 1989) . The reactions contained 110 mM NaCl, 8 mM MgCl 2 , 20 mM HEPES pH 7.8, 200 mM ATP, CTP, UTP, 12 mM GTP, 15 mM [a-32P]GTP (3000 Ci/mmol ), 75 fmol template tRNA gene, and pIBI DNA as carrier (for a total of 1 mg DNA/reaction) in a volume of 50 ml. Single-round in vitro transcriptions were performed by pre-incubating the template DNA for 10 min at room temperature with all reaction components, except GTP and [a-32P]GTP, to form a transcription complex on the DNA. Then, heparin (80 mg/ml ), GTP, and [a-32P]GTP were added, and the reaction was incubated at room temperature for an additional 10 min. Products were extracted with phenol/chloroform and precipitated with ethanol in the presence of 2.5 M NH 4 OAc, washed with 70% ethanol, and dried. The products were resuspended in 5 ml TE, and 2 ml was used in the primer extension reactions. Oligonucleotide primer 357, complementary to the htRNA 3 Lys sequences +24 to +51 (5∞-CTGGACCCTCAGATTAAAAGTCTGATGC-3∞), was labeled at the 5∞ end with 32P using T4 polynucleotide kinase and [c-32P] . Approximately 1 ng oligonucleotide was annealed to the template RNA (20 mg for yeast RNA or 40 mg for HeLa RNA) and extended using purified reverse transcriptase (Life Sciences, Inc.) by the method of Carey et al. (1986) . Products of primer extension reactions were treated with RNase A and RNase H for 30 min at 37°C to remove (a-32P)-labeled RNA. Primer extension products were visualized by electrophoresis in 10% polyacrylamide/bis (20:1)/7 M urea gels followed by autoradiography. The DNA sequence ladder was synthesized by annealing the (c-32P)-labeled oligonucleotide 357 to htRNA 3 Lys plasmid DNA and extending with Sequenase ( U.S. Biochemicals) in the presence of dideoxynucleotides. All reactions were electrophoresed on the same gel; in the figure, lanes 1-6 represent an exposure time of approximately half that of the remaining lanes. The C56 to G56 promoter mutation in the htRNA 3 Lys gene was generated via single-stranded oligonucleotide mutagenesis ( Kunkel, 1985) using the oligonucleotide 5∞-ACAGGGACTTCACCCCTGGA-3∞, which is complementary to htRNA 3 Lys. The underlined C nucleotide mutates the C at position 56 to a G in the box B promoter element. stranded oligonucleotide mutagenesis. As expected, in reactions performed on in vitro transcription reactions with carrier DNA, pIBI-20 ( lane 3) and the vector vitro transcription reactions using the G56 mutant template, followed by primer extension analysis, failed to backbone, pM13IIKS+ ( lane 4) also did not yield any product. yield a product ( lanes 5 and 6). Control extension The 'H' followed by an arrow indicates the site of transcription initiation when heparin is present in the in vitro transcription reaction. Methods: Following the assay described in Fig. 1 , DNA was isolated from yeast cells which had undergone a transposition event (G418 and 5-FOA resistant) and used to transform E. coli to both ampicillin and kanamycin resistance. Plasmid DNA was extracted from E. coli transformants (Ausubel et al., 1997) . The position of Ty3 integrations was determined by DNA sequence analysis using the method of Sanger et al. (1977) , the Sequenase enzyme ( U.S. Biochemicals), and oligonucleotide 357, which is complementary to the htRNA 3 Lys gene.
Ty3 integration adjacent to the human tRNA 3
Lys contains an integrated, galactose-inducible, Ty3 helper element that is required to provide the essential proteins target in trans because the Ty3 coding region is disrupted by the NmR gene. The Ty3-N element was placed on a lowHigh-level expression of Ty3 RNA results in Ty3 transposition into sites upstream of genomic tRNA copy, URA3-marked plasmid, to produce the donor plasmid pDLC348. genes (Hansen et al., 1988; Chalker and Sandmeyer, 1990) . A transposition assay was developed to recover The human tRNA 3 Lys gene was cloned on to a highcopy, LYS2-marked plasmid to provide multiple plasmid transposed elements in target plasmids independent of the site of integration (Chalker and Sandmeyer, 1992) . targets per cell. Three identical copies of the target plasmid were used independently in this assay, This assay was used to manipulate the target gene and show that a transcriptionally-competent, RNA polymerpSD1448A-C. Each of the target plasmids was transformed independently along with the donor plasmid ase III-transcribed gene was necessary to target integration (Chalker and Sandmeyer, 1992) . The transpDLC348 into the yeast strain yDLC221. The assay and selection procedure were carried out as described in position assay has been used in this study to determine whether a gene transcribed by pol III, from a heterolo- Fig. 1 . For each target plasmid, 12 integration events were analyzed (G418 and 5-FOA resistant). The concengous organism can be used as a target for transposition. In this assay, summarized in Fig. 1 , the donor Ty3 tration of G418 (700 mg/ml ) used enriched for cells in which Ty3-N insertions had occurred into the high-copy element, Ty3-N, was tagged with the bacterial NmR gene, which confers G418 resistance in yeast and kanatarget plasmid. In two out of 36 selected colonies, there was no growth on medium lacking lysine, indicating mycin resistance in E. coli. Transposition experiments were performed using yeast strain yDLC221. This strain that these clones may have undergone more than one chromosomal integration. In order to analyze the integNone the less, we believe this is the first report of a human tRNA gene transcribed in a yeast system. ration events into the target DNA, the plasmids were rescued in E. coli and selected for growth on ampicillin
The human tRNA 3 Lys gene served as a target for Ty3 integration in an in vivo assay. Analysis of all recovered and kanamycin. From the 34 clones that had undergone plasmid-based integration events, plasmids were rescued integration events revealed that Ty3 integrated adjacent to the site of transcription initiation and in an orientafrom 27 as ApR/KmR colonies in E. coli. Restriction enzyme analysis was performed to verify the presence tion-independent manner, similar to that seen when using a yeast tRNA gene as a target. This assay is not of the Ty3-N element on the rescued plasmids (data not shown). Once the presence of the Ty3-N element was quantitative, and therefore a direct comparison of the efficiency of integration of the human tRNA 3 Lys gene verified, positions of the integration events were determined via sequence analysis of the target plasmids.
and a yeast tRNA gene cannot be made. Such a comparison is also complicated by the lack of information In order to determine the exact location of the integration of Ty3, the rescued plasmids were sequenced with concerning the relative usage of different yeast tRNA genes as targets for Ty3 transposition. The recently an oligonucleotide primer specific to the htRNA 3 Lys gene. The sequence was determined for 25 of the rescued completed genomic sequence of Saccharomyces cerevisae shows that diverse tRNA genes have been used as plasmids, and the position of Ty3 integration relative to the proposed site(s) of transcription initiation on the targets for Ty3 transposition. It is not known whether these genes represent a preferred subset of tRNA gene htRNA 3 Lys gene is shown in Fig. 3 . Upon integration, Ty3 makes a 5-bp staggered cut in the target DNA targets, and if so, what factors influenced the use of these tRNA genes out of the 275 total tRNA genes in (Clark et al., 1988) . The position of the nick closest to the tRNA gene is indicated in the figure. In addition, the genome (Goffeau et al., 1996) . Integration can now be further studied to determine whether human tranTy3 can integrate in either orientation relative to the tRNA gene target, as illustrated in Fig. 3 . Integrations scription factors can substitute for the yeast transcription factors and target Ty3 integration to a human were observed in both orientations at equivalent frequencies. The integrations clustered around positions -7 tRNA gene. This will be an important step in determining whether the position-specific integration properties and -13. The 5∞-end mapping analysis identified position -13 and the three bases upstream as the primary tranof Ty3 can be incorporated into a retroviral-based gene therapy vector. scription initiation sites, although products corresponding to position -7 were also observed in both in vitro and in vivo transcription experiments. Therefore, -7 may be a minor initiation site. The majority of integration Acknowledgement events (18 out of 25) were targeted to the region around the primary initiation site at nucleotide -13, whereas
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